Cell-Based Therapy for Spinal Muscular Atrophy
- PMID: 33105498
- DOI: 10.1007/978-981-15-4370-8_8
Cell-Based Therapy for Spinal Muscular Atrophy
Abstract
Spinal muscular atrophy (SMA) is a devastating neurodegenerative disease characterized by the degeneration of lower motor neurons in the spinal cord, leading to progressive paralysis and early death in the severe cases. SMA is primarily caused by the mutations in the gene of SMN (survival motor neuron). More research has focused on the development of SMN-targeted replacement therapy for SMA. The first US Food and Drug Administration (FDA)-approved modified antisense oligonucleotide (nusinersen) to treat SMA is to reverse intronic splicing silencer of SMN to produce fully functional SMN2. Recently, stem cell transplantation has shown the potential to repair the injured tissue and differentiate into neurons to rescue the phenotypes of SMA in animal models. In this chapter, we first review the clinical, genetic, and pathogenic mechanisms of SMA. Then, we discuss current pharmacological treatments and point out the therapeutic efficacy of stem cell transplantation and future directions and priorities for SMA.
Keywords: Motor neuron; Mutation; Spinal muscular atrophy; Stem cell; Survival motor neuron (SMN).
Similar articles
-
Combined treatment with the histone deacetylase inhibitor LBH589 and a splice-switch antisense oligonucleotide enhances SMN2 splicing and SMN expression in Spinal Muscular Atrophy cells.J Neurochem. 2020 Apr;153(2):264-275. doi: 10.1111/jnc.14935. Epub 2020 Jan 8. J Neurochem. 2020. PMID: 31811660
-
Motor neuron cell-nonautonomous rescue of spinal muscular atrophy phenotypes in mild and severe transgenic mouse models.Genes Dev. 2015 Feb 1;29(3):288-97. doi: 10.1101/gad.256644.114. Epub 2015 Jan 12. Genes Dev. 2015. PMID: 25583329 Free PMC article.
-
Challenges and future perspective of antisense therapy for spinal muscular atrophy: A review.Eur J Cell Biol. 2023 Jun;102(2):151326. doi: 10.1016/j.ejcb.2023.151326. Epub 2023 Jun 2. Eur J Cell Biol. 2023. PMID: 37295266 Review.
-
Nusinersen in the Treatment of Spinal Muscular Atrophy.Methods Mol Biol. 2018;1828:69-76. doi: 10.1007/978-1-4939-8651-4_4. Methods Mol Biol. 2018. PMID: 30171535 Review.
-
Restoring SMN Expression: An Overview of the Therapeutic Developments for the Treatment of Spinal Muscular Atrophy.Cells. 2022 Jan 26;11(3):417. doi: 10.3390/cells11030417. Cells. 2022. PMID: 35159227 Free PMC article. Review.
Cited by
-
Spinal Cord Organoids to Study Motor Neuron Development and Disease.Life (Basel). 2023 May 25;13(6):1254. doi: 10.3390/life13061254. Life (Basel). 2023. PMID: 37374039 Free PMC article. Review.
-
Harnessing the Stem Cell Niche in Regenerative Medicine: Innovative Avenue to Combat Neurodegenerative Diseases.Int J Mol Sci. 2024 Jan 12;25(2):993. doi: 10.3390/ijms25020993. Int J Mol Sci. 2024. PMID: 38256066 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical